Recruiting Interstitial Lung Disease Studies in Bethesda
About Interstitial Lung Disease Clinical Trials in Bethesda
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 3 interstitial lung disease clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 580 participants. Research is being sponsored by Hackensack Meridian Health, National Institute of Mental Health (NIMH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in Bethesda — FAQ
Are there interstitial lung disease clinical trials in Bethesda?
Yes, there are 3 interstitial lung disease clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Bethesda?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.
Are clinical trials in Bethesda free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 3 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated July 13, 2026 from ClinicalTrials.gov